Relating phthalate and BPA exposure to metabolism in peripubescence: The role of exposure timing, sex, and puberty

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 1, 2016, Pages 79-88

  Watkins, Deborah J ^a   Peterson, Karen E ^a,b   Ferguson, Kelly K ^a   Mercado Garcia, Adriana ^c   Tamayoy Ortiz, Marcela ^c   Cantoral, Alejandra ^c   Meeker, John D ^a   Téllez Rojo, Martha Maria ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BIOLOGICAL MARKER; C PEPTIDE; GLUCOSE; LEPTIN; MONO 3 CARBOXYPROPYL PHTHALATE; MONOBENZYL PHTHALATE; PHTHALIC ACID; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DIBUTYL ESTER; SOMATOMEDIN C; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; ENDOCRINE DISRUPTOR; GLUCOSE BLOOD LEVEL; PHENOL DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL STAGE; FEMALE; FOLLOW UP; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MALE; METABOLIC REGULATION; MEXICO; PERIPUBESCENCE; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; PUBERTY; SENSITIVITY ANALYSIS; ADULT; ADVERSE EFFECTS; ANALYSIS; BLOOD; COHORT ANALYSIS; DRUG EFFECTS; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NEWBORN; PREGNANCY; SEX DIFFERENCE; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; BENZHYDRYL COMPOUNDS; BIOMARKERS; BLOOD GLUCOSE; COHORT STUDIES; DIETHYLHEXYL PHTHALATE; ENDOCRINE DISRUPTORS; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; FEMALE; HOMEOSTASIS; HUMANS; INFANT, NEWBORN; INSULIN RESISTANCE; LEPTIN; LONGITUDINAL STUDIES; MALE; MEXICO; MIDDLE AGED; PHENOLS; PREGNANCY; PUBERTY; SEX FACTORS; YOUNG ADULT;

EID: 84954479032     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2706     Document Type: Article

References (38)

1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766-781.
2. Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: A systematic review of the literature. Metab Syndr Relat D. 2013;11:71-80.
3. Evia-Viscarra ML, Rodea-Montero ER, Apolinar-Jiménez E, Quintana-Vargas S. Metabolic syndrome and its components among obese (BMI-95th) Mexican adolescents. Endocr Connect. 2013; 2:208-215.
4. Grün F, Blumberg B. Endocrine disrupters as obesogens. Mol Cell Endocrinol. 2009;304:19-29.
5. United States Department of Health and Human Services. Fourth National Report on Human Exposure to Environmental Chemicals. Updated Tables, February 2015. [press release]. Centers for Disease Control and Prevention: Atlanta, GA; 2015.
6. Trasande L, Spanier AJ, Sathyanarayana S, Attina TM, Blustein J. Urinary phthalates and increased insulin resistance in adolescents. Pediatrics. 2013;132:e646-e655.
7. Huang T, Saxena AR, Isganaitis E, James-Todd T. Gender and racial/ethnic differences in the associations of urinary phthalate metabolites with markers of diabetes risk: National Health and Nutrition Examination Survey 2001-2008. Environ Health-Glob. 2014; 13:6.
8. Boas M, Frederiksen H, Feldt-Rasmussen U, et al. Childhood exposure to phthalates: Associations with thyroid function, insulin-like growth factor I, and growth. Environ Health Perspect. 2010;118: 1458-1464.
9. LeRoith D, Yakar S. Mechanisms of disease: Metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract. Endocrinol Metab. 2007;3:302-310.
10. Ashley-Martin J, Dodds L, Arbuckle TE, et al. A birth cohort study to investigate the association between prenatal phthalate and bisphenol A exposures and fetal markers of metabolic dysfunction. Environ Health-Glob. 2014;13:84.
11. Allison MB, Myers MG Jr. 20 years of leptin: Connecting leptin signaling to biological function. J Endocrinol. 2014;223:T25-T35.
12. Walsh JM, Byrne J, Mahony RM, Foley ME, McAuliffe FM. Leptin, fetal growth and insulin resistance in non-diabetic pregnancies. Early Hum Dev. 2014;90:271-274.
13. Monti V, Carlson JJ, Hunt SC, Adams TD. Relationship of ghrelin and leptin hormones with body mass index and waist circumference in a random sample of adults. JAmDiet Assoc. 2006;106:822-828; quiz 829-830.
14. Zuo H, Shi Z, Yuan B, Dai Y, Wu G, Hussain A. Association between serum leptin concentrations and insulin resistance: A population-based study from China. PLoS One. 2013;8:e54615.
15. Eng DS, Lee JM, Gebremariam A, Meeker JD, Peterson K, Padmanabhan V. Bisphenol A and chronic disease risk factors in US children. Pediatrics. 2013;132:e637-e645.
16. Volberg V, Harley K, Calafat AM, et al. Maternal bisphenol a exposure during pregnancy and its association with adipokines in Mexican-American children. Environ Mol Mutagen. 2013;54:621-628.
17. Rönn M, Lind L, Örberg J, et al. BisphenolAis related to circulating levels of adiponectin, leptin and ghrelin, but not to fat mass or fat distribution in humans. Chemosphere. 2014;112:42-48.
18. Wang T, Li M, Chen B, et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab. 2012;97:E223-E227.
19. Lewis RC, Meeker JD, Peterson KE, et al. Predictors of urinary bisphenol A and phthalate metabolite concentrations in Mexican children. Chemosphere. 2013;93:2390-2398.
20. Bonser AM, Garcia-Webb P. C-peptide measurement: Methods and clinical utility. Crit Rev Clin Lab Sci. 1984;19:297-352.
21. Lee EY, Hwang S, Lee SH, et al. Postprandial C-peptide to glucose ratio as a predictor of-cell function and its usefulness for staged management of type 2 diabetes. J Diabetes Investig. 2014;5:517-524.
22. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-1495.
23. MarshallWA,Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.
24. World Health Organization. Growth reference data for 5-19 years. 2015. Available at http://www.who.int/growthref/en/. Accessed April 1, 2015.
25. Gardner DG, Shoback D. Appendix: Normal hormone reference ranges. In: Greenspan's Basic and Clinical Endocrinology, 9th ed. 2011.
26. Autian J. Toxicity and health threats of phthalate esters: Review of the literature. Environ Health Perspect. 1973;4:3-26.
27. Haugen AC, Schug TT, Collman G, Heindel JJ. Evolution of DOHaD: The impact of environmental health sciences. J Dev Orig Health Dis. 2014:1-10.
28. Fortenberry GZ, Meeker JD, Sánchez BN, et al. Urinary 3,5,6-trichloro-2-pyridinol (TCPY) in pregnant women from Mexico City: Distribution, temporal variability, and relationship with child attention and hyperactivity. Int J Hyg Environ Health. 2014;217:405-412.
29. Ahmadian M, Suh JM, Hah N, et al. PPAR-signaling and metabolism: The good, the bad and the future. NatMed. 2013;19:557-566.
30. Hurst CH, Waxman DJ. Activation of PPAR-and PPAR-by environmental phthalate monoesters. Toxicol Sci. 2003;74:297-308.
31. Taxvig C, Dreisig K, Boberg J, et al. Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPAR-activation. Mol Cell Endocrinol. 2012; 361:106-115.
32. Jalouli M, Carlsson L, Améen C, et al. Sex difference in hepatic peroxisome proliferator-activated receptor-expression: Influence of pituitary and gonadal hormones. Endocrinology. 2003;144:101-109.
33. Watkins DJ, Ferguson KK, Anzalota Del Toro LV, Alshawabkeh AN, Cordero JF, Meeker JD. Associations between urinary phenol and paraben concentrations and markers of oxidative stress and inflammation among pregnant women in Puerto Rico. Int J Hyg Environ Health. 2015;218:212-219.
34. Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. Urinary phthalate metabolites and biomarkers of oxidative stress in pregnant women: A repeated measures analysis. Environ Health Perspect. 2015;123:210-216.
35. Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med. 2011;51:993-999.
36. Sathyanarayana S, Alcedo G, Saelens BE, et al. Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures. J Expo Sci Environ Epidemiol. 2013;23:378-384.
37. Cantonwine DE, Cordero JF, Rivera-González LO, et al. Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: Distribution, temporal variability, and predictors. Environ Int. 2014;62:1-11.
38. Meeker JD, Cantonwine DE, Rivera-González LO, et al. Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico. Environ Sci Technol. 2013;47:3439-3447.